Psychometric validation of the Brain Symptom and Impact Questionnaire (BASIQ) version 1.0 to assess quality of life in patients with brain metastases

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1 Serres S, Soto MS, Hamilton A et al. Molecular MRI enables early and sensitive detection of brain metastases. Proc. Natl Acad. Sci. USA 109(17), 6674–6679 (2012).
  Medline CASGoogle Scholar
• 2 Doyle M, Bradley NM, Li K et al. Quality of life in patients with brain metastases treated with a palliative course of whole-brain radiotherapy. J. Palliat. Med. 10(2), 367–374 (2007).
  MedlineGoogle Scholar
• 3 Thomas SS, Dunbar EM. Modern multidisciplinary management of brain metastases. Curr. Oncol. Rep. 12(1), 34–40 (2010).• Comprehensive review of current treatment options available for patients with brain metastases.
  MedlineGoogle Scholar
• 4 Eichler AF, Loeffler JS. Multidisciplinary management of brain metastases. Oncologist 12(7), 884–898 (2007).
  Medline CASGoogle Scholar
• 5 Chang EL, Wefel JS, Maor MH et al. A pilot study of neurocognitive function in patients with one to three new brain metastases initially treated with stereotactic radiosurgery alone. Neurosurgery 60(2), 277–283 (2007).
  MedlineGoogle Scholar
• 6 Posner JB. Management of central nervous system metastases. Semin. Oncol. (1), 81–91 (1977).
  Google Scholar
• 7 Tsao MN, Lloyd N, Wong R, Chow E, Rakovitch E, Laperriere N. Whole brain radiotherapy for the treatment of multiple brain metastases. Cochrane Database Syst. Rev. (3), CD003869 (2006).
  MedlineGoogle Scholar
• 8 Movsas B. Quality of life in oncology trials: a clinical guide. Semin. Radiat. Oncol. 13(3), 235–247 (2003).
  MedlineGoogle Scholar
• 9 Caissie A, Nguyen J, Chen E et al. Quality of life in patients with brain metastases using the EORTC QLQ-BN20+2 and QLQ-C15-PAL. Int. J. Radiat. Oncol. Biol. Phys. 83(4), 1238–1245 (2012).
  MedlineGoogle Scholar
• 10 Chen E, Cella D, Zeng L et al. Content validation of the FACT-Br with patients and health-care professionals to assess quality of life in patients with brain metastases. J. Radiat. Oncol. 3(1), 105–113 (2012).•• Study of similar nature to the present study, which validated the use of the FACT-Br in patients with brain metastases.
  Google Scholar
• 11 Campos S, Davey P, Hird A et al. Brain metastasis from an unknown primary, or primary brain tumour? A diagnostic dilemma. Curr. Oncol. 16(1), 62–66 (2009).
  Medline CASGoogle Scholar
• 12 Caissie A, Culleton S, Nguyen J et al. EORTC QLQ-C15-PAL quality of life scores in patients with advanced cancer referred for palliative radiotherapy. Support. Care Cancer 20(4), 841–848 (2012).
  MedlineGoogle Scholar
• 13 Bedard G, Ray S, Zhang L et al. Content validation of the brain symptom and impact questionnaire (BASIQ) in patients and health-care professionals to assess quality of life in patients with brain metastases. Support. Care Cancer. 21(Suppl. 1), S132 (2013).•• First phase of the present study, which involved the content validation for the Brain Metastases Symptom and Impact Questionnaire (BASIQ) questionnaire.
  Google Scholar
• 14 Cicchetti DV, Sparrow SA. Developing criteria for establishing interrater reliability of specific items: applications to assessment of adaptive behavior. Am. J. Ment. Defic. 86(2), 127–137 (1981).
  Medline CASGoogle Scholar
• 15 Nunnally JC, Bernstein IH. Psychometric Theory (3rd Edition). Mc Graw-Hill, NY, USA (1994).
  Google Scholar
• 16 Johnson C, Fitzsimmons D, Gilbert J et al. Development of the European Organisation for Research and Treatment of Cancer quality of life questionnaire module for older people with cancer: the EORTC QLQ-ELD15. Eur. J. Cancer. 46(12), 2242–2252 (2010).
  MedlineGoogle Scholar
• 17 Wong J, Hird A, Zhang L et al. Symptoms and quality of life in cancer patients with brain metastases following palliative radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 75(4), 1125–1131 (2009).• Examines quality of life and symptoms in patients with brain metastases follow palliative radiotherapy, which is a similar patient population to the present study.
  MedlineGoogle Scholar
• 18 Li J, Bentzen SM, Li J, Renschler M, Mehta MP. Relationship between neurocognitive function and quality of life after whole-brain radiotherapy in patients with brain metastasis. Int. J. Radiat. Oncol. Biol. Phys. 71(1), 64–70 (2008).
  MedlineGoogle Scholar
• 19 Friendlander AH, Ettinger RL. Karnofsky performance status scale. Spec. Care Dentist. 29(4), 147–148 (2009).
  MedlineGoogle Scholar
• 20 Hempen C, Weiss E, Hess CF. Dexamethasone treatment in patients with brain metastases and primary brain tumors: do the benefits outweigh the side-effects? Support. Care Cancer. 10(4), 322–328 (2002).
  MedlineGoogle Scholar
• 21 Bezjak A, Adam J, Barton R et al. Symptom response after palliative radiotherapy for patients with brain metastases. Eur. J. Cancer. 38(4), 487–496 (2002).
  Medline CASGoogle Scholar